Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
Status: | Recruiting |
---|---|
Conditions: | Alzheimer Disease, Cognitive Studies, Cognitive Studies, Neurology |
Therapuetic Areas: | Neurology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 50 - 90 |
Updated: | 9/30/2018 |
Start Date: | September 2015 |
End Date: | September 2020 |
Contact: | Andrew E Budson, MD |
Email: | abudson@bu.edu |
The current study will examine the use of a mobile electronic application used to deliver
cognitive rehabilitation to patients with mild cognitive impairment due (MCI) due to
Alzheimer's disease (AD), and patients with mild AD. Patients will be given a specific
cognitive rehabilitation program on their mobile device (iPad) with specific tasks for them
to complete. The goal of this study is to determine if a) patients are able to use and adhere
to a cognitive rehabilitation program delivered to their mobile device and b) to determine if
patients can improve their language, attention, and memory by completing cognitive
rehabilitation tasks assigned to them.
cognitive rehabilitation to patients with mild cognitive impairment due (MCI) due to
Alzheimer's disease (AD), and patients with mild AD. Patients will be given a specific
cognitive rehabilitation program on their mobile device (iPad) with specific tasks for them
to complete. The goal of this study is to determine if a) patients are able to use and adhere
to a cognitive rehabilitation program delivered to their mobile device and b) to determine if
patients can improve their language, attention, and memory by completing cognitive
rehabilitation tasks assigned to them.
In the current study, the investigators are examining the use of a mobile electronic
application used to deliver cognitive rehabilitation tasks to patients with mild cognitive
impairment due to Alzheimer's disease, and patients with mild Alzheimer's disease. An
estimated 100 patients will be enrolled into the study (~50 patients with mild cognitive
impairment, ~50 patients with Alzheimer's disease).
Participants will either receive memory tasks designed to help stabilize or improve memory
(Intervention Group) or a set of word or math puzzles (Control Group). Participants will
complete memory tasks or puzzles for a six month period. The investigators will conduct pre-
and post- neuropsychological testing to assess changes in cognitive status (e.g., memory,
language, executive functioning) in the intervention group. Neuropsychological tests
assessing changes to cognition will be completed prior to participant assignment to the
Intervention or Control Group. Both groups will then be assessed again using
neuropsychological tests. The investigators will also assess changes in performance on
cognitive rehabilitation tests over the six month period to determine the efficacy of these
tasks.
application used to deliver cognitive rehabilitation tasks to patients with mild cognitive
impairment due to Alzheimer's disease, and patients with mild Alzheimer's disease. An
estimated 100 patients will be enrolled into the study (~50 patients with mild cognitive
impairment, ~50 patients with Alzheimer's disease).
Participants will either receive memory tasks designed to help stabilize or improve memory
(Intervention Group) or a set of word or math puzzles (Control Group). Participants will
complete memory tasks or puzzles for a six month period. The investigators will conduct pre-
and post- neuropsychological testing to assess changes in cognitive status (e.g., memory,
language, executive functioning) in the intervention group. Neuropsychological tests
assessing changes to cognition will be completed prior to participant assignment to the
Intervention or Control Group. Both groups will then be assessed again using
neuropsychological tests. The investigators will also assess changes in performance on
cognitive rehabilitation tests over the six month period to determine the efficacy of these
tasks.
Inclusion Criteria:
- A diagnosis of mild cognitive impairment due to Alzheimer's disease (MCI due to AD) by
the patient's referring clinician per recent National Institutes of Aging-Alzheimer's
Association criteria (Albert et al., 2011).
- A diagnosis of mild Alzheimer's disease by the patient's referring clinician per
recent National Institutes of Aging-Alzheimer's Association criteria (McKhann et al.,
2011).
- 50-90 years of age.
Exclusion Criteria:
- Younger than the age of 50 or older than the age of 90.
- Any self-reported history of substance abuse or alcohol abuse.
- Any self-reported history of prior head trauma (e.g., stroke, traumatic brain injury)
- Any prior self-reported history of significant depression or other mood disorder.
We found this trial at
1
site
72 East Concord Street
Boston, Massachusetts 02118
Boston, Massachusetts 02118
(617) 638-5300
Boston University School of Medicine A leader in medical education and research, Boston University School...
Click here to add this to my saved trials